Abstract
Because of joint haemorrhages, severe haemophilia subjects often have limitations in their daily activities. Current orthopaedic scores (OJS) in haemophilia miss mild joint impairments and only pick up severe alterations. Twelve young severe haemophiliacs (20.25 ± 1.9 years of age), were evaluated for OJS as well as for indices employed in rheumatoid arthritis [28-joint Disease Activity Score (DAS-28), Ritchie index, Health Assessment Questionnaire (HAQ), visual analogue scale (VAS)], spondyloarthritis [Bath Ankylosing Spondylitis Disease Activity Index (BASDAI), HAQ, VAS] and osteoarthritis [Knee injury and Osteoarthritis Outcome Score (KOOS), VAS]. Twenty-four matched apparently healthy subjects and 29 subjects with psoriatic arthritis (PsA) with oligoarticular involvement (one to three swollen joints) served as controls. In addition to the impairment of target joints (elbow, in five of five in those on-demand treatment; three, elbows; four, knee in those on secondary prophylaxis), HAQ (mean 0.71 ± 0.95) and VAS (3.12 ± 2.36) documented a quality of life and a perception of pain in haemophiliacs similar to that of PsA subjects (p = 0.061 and p = 0.063, respectively). Their Ritchie index did not differ from that of subjects with psoriatic arthritis (5.75 ± 8.1 vs 7.73 ± 9.22; p = 0.408), nor did the BASDAI score with respect to psoriatic arthritis patients (p = 0.105). Six of 12 haemophiliacs (50%) had KOOS values from 70 to 50 (significant function joint impairment); 3 of 12 (25%) showed DAS-28 values >3.2 (moderate disease activity), 2 of 12 (16.6%) severe disease activity (>5.1). All these indices significantly correlated with VAS and HAQ in haemophilia subjects. A rheumatologic assessment may help identify early polyarticular disease and subclinical abnormalities involving joints not usually studied (not target joint) in haemophiliacs. These pilot data provide the rationale for testing a systemic involvement in haemophiliacs by means of high-tech imaging and to start early-onset prophylaxis/treatment in this setting.
Similar content being viewed by others
References
Stein H, Duthie RB (1981) The pathogenesis of chronic haemophilic arthropathy. J Bone Joint Surg Br 63B:601–609
Madhok R, York J, Sturrock RD (1991) Haemophilic arthritis. Ann Rheum Dis 50:588–591
Zeman DH, Roberts ED, Shoji H, Miwa T (1991) Experimental haemarthrosis in rhesus monkeys: morphometric, biochemical and metabolic analyses. J Comp Pathol 104:129–139
Roy S, Ghadially FN (1966) Pathology of experimental haemarthrosis. Ann Rheum Dis 25:402–415
Gilbert MS (1993) Prophylaxis: musculoskeletal evaluation. Semin Hematol 30(suppl 2):3–6
Poonnoose PM, Manigandan C, Thomas R et al (2005) Functional independence score in haemophilia (FISH): a new performance-based instrument to measure disability. Haemophilia 11:598–602
Hacker MR, Funk SM, Manco-Johnson MJ et al (2007) The Colorado haemophilia paediatric joint physical examination scale: normal values and interrater reliability. Haemophilia 13:71–78
Di Minno MND, Iervolino S, Peluso R, Scarpa R, Di Minno G; on behalf of the CaRRDs study group (2011) Carotid intima-media thickness in psoriatic arthritis: differences between tumor necrosis factor-{alpha} blockers and traditional disease-modifying antirheumatic drugs. Arterioscler Thromb Vasc Biol (in press)
Taylor WJ, Harrison AA (2004) Could the Bath Ankylosing Spondylitis Disease Activity Index (BASDAI) be a valid measure of disease activity in patients with psoriatic arthritis? Arthritis Rheum 51:311–315
Gladman DD, Mease PJ, Healy P, Helliwell PS, Fitzgerald O, Cauli A, Lubrano E, Krueger GG, van der Heijde D, Veale DJ, Kavanaugh A, Nash P, Ritchlin C, Taylor W, Strand V (2007) Outcome measures in psoriatic arthritis. J Rheumatol 34(5):1159–1166
Ritchie DM, Boyle JA, McInnes JM et al (1968) Clinical studies with an articular index for the assessment of joint tenderness in patients with rheumatoid arthritis. Q J Med 37:393–406
Van der Heijde DMFM, Johannes WG, Jacobs JWG (1998) The original “DAS” and the “DAS28” are not interchangeable: comment on the article by Prevoo et al. Arthritis Rheum 41(5):942–950
Garrett S, Jenkinson T, Kennedy G, Whitelock H, Gaisford P, Calin A (1994) A new approach to defining disease status in ankylosing spondylitis: the Bath Ankylosing Spondylitis Activity index. J Rheumatol 21:2286–2291
Myles PS, Troedel S, Boquest M, Reeves M (1999) The pain visual analog scale: is it linear or nonlinear? Anesth Analg 89:1517–1520
Bruce B, Fries JF (2003) The Stanford Health Assessment Questionnaire: a review of its history, issues, progress, and documentation. J Rheumatol 30:167–178
Roos EM, Roos HP, Lohmander LS, Ekdahl C, Beynnon BD (1998) Knee Injury and Osteoarthritis Outcome Score (KOOS) development of a self-administred outcome measure. J Orthop Sports Phys Ther 28(2):88–96
Scarpa R, Oriente P, Pucino A, Vignone L, Cosentini E, Minerva A, Biondi Oriente C (1988) The clinical spectrum of psoriatic spondylitis. Br J Rheumatol 27(2):133–137
Roosendaal G, Lafeber FP (2006) Pathogenesis of haemophilic arthropathy. Haemophilia 12(suppl 3):117–121
Wen FQ, Jabbar AA, Chen YX, Kazarian T, Patel DA, Valentino LA (2002) c-myc proto-oncogene expression in hemophilic synovitis: in vitro studies of the effects of iron and ceramide. Blood 100:912–916
Valentino LA, Hakobyan N, Kazarian T, Jabbar KJ, Jabbar AA (2004) Experimental haemophilic synovitis: rationale and development of a murine model of human factor VIII deficiency. Haemophilia 10:280–287
Hakobyan N, Kazarian T, Valentiono LA (2005) Synovitis in a murine model of human factor VIII deficiency. Haemophilia 11:227–232
Hakobyan N, Kazarian T, Jabbar AA, Jabbar KJ, Valentiono LA (2004) Pathobiology of hemophilic synovitis: overexpression of mdm2 oncogene. Blood 104:2060–2064
Roosendaal G, Vianen ME, Marx JJM, van den Berg HM, Lafeber FPJG, Bijlsma JWJ (1999) Blood induced joint damage: a human in vitro study. Arthritis Rheum 42:1025–1032
Hooiveld MJJ, Roosendaal G, van den Berg HM, Bijlsma JWJ, Lafeber FPJG (2003) Blood-induced joint damage: long-term effects in vivo and in vitro. J Rheumatol 30:339–344
Roosendaal G, Van Rinsum AC, Vianen ME, van den Berg HM, Lafeber FPJG, Bijlsma JWJ (1999) Haemophilic arthropathy resembles degenerative rather than inflammatory joint disease. Histopathology 34:144–153
Disclosures
All the authors have revised and approved the present manuscript.
Professor Giovanni Di Minno, Professor Raffaele Scarpa and Doctor Antonio Coppola did not receive specific funding for the preparation of this manuscript. During the last 5 years, they served on advisory boards and received honoraria and grants for research unrelated to this study. The other authors have nothing to declare.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Di Minno, M.N.D., Iervolino, S., Peluso, R. et al. Assessing joint involvement in haemophilia by clinical rheumatologic scores. A pilot study on similarities with subjects with psoriatic arthritis. Clin Rheumatol 30, 915–919 (2011). https://doi.org/10.1007/s10067-011-1707-4
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10067-011-1707-4